SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Blichert-Toft M, Rose C, Andersen JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr. 1992; 11: 1925.
  • 2
    Van Dongen JA, Voogd AC, Fentiman SI, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst. 2000; 92: 11431150.
  • 3
    Jacobson JA, Danforth DN Jr., Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995; 332: 907911.
  • 4
    Arriagada R, Le MG, Rochard F, et al. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol. 1996; 14: 15581564
  • 5
    Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 12331241.
  • 6
    Veronsei U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 12271232.
  • 7
    Albain KS, Green SR, Lichter AS, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996; 14: 30093017.
  • 8
    Madan AK, Aliabadi-Wahle S, Beech DJ. Age bias: a cause of underutilization of breast conservation treatment. J Cancer Educ. 2001; 16: 2932.
  • 9
    Straus K, Lichter A. Lippman M, et al. Results of the National Cancer Institute early breast cancer trial. J Natl Cancer Inst Monogr. 1992; 11: 2732.
  • 10
    Lichter AS, Lippman ME, Danforth DN Jr., et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992; 11: 2732.
  • 11
    Danforth DN Jr., Findlay PA, McDonald HD, et al. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol. 1986; 4: 655662.
  • 12
    Lichter AS, Fraas BA, Fredrickson HA, et al. Computed tomography in treatment planning: primary breast cancer. In: LingCC, RogersCC, MortonRJ, editors. Computed tomography in radiation therapy. New York: Raven Press, 1983: 99107.
  • 13
    Fraas BA, Lichter AS, Fredrickson HA, et al. The influence of lung density corrections on treatment planning for primary breast cancer. Int J Radiat Oncol Biol Phys. 1988; 14: 179190.
  • 14
    Lippman ME, Edwards BK, Findlay P, et al. Influence of definitive radiation therapy for primary breast cancer on ability to deliver adjuvant chemotherapy. NCI Monogr. 1986; 1: 99104.
  • 15
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958; 53: 457481.
  • 16
    Mantel N. Chi-square tests with one degree of freedom: extensions of the Mantel–Haensel procedure. J Am Stat Assoc. 1963; 58: 690700.
  • 17
    Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med. 1995; 333: 14441455.
  • 18
    Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet. 2000; 355: 17571770.
  • 19
    Freedman GM, Hanlon AL, Fowble BL, Anderson PR, Nicoloau N. Recursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiation. J Clin Oncol. 2002; 20: 40154021.
  • 20
    Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000; 18: 16681675.